PCCA developed UniFlow specifically to meet the needs of compounding highly potent, low-dose APIs such as T3 and T4. It delivers consistent trituration uniformity, reducing variability in results, while incorporating advancements in excipient technology to enhance moisture control and powder flow. This combination ensures reliability, precision and ease of use in preparing thyroid hormone formulations.